Spots Global Cancer Trial Database for A Study of Nivolumab Alone or Nivolumab Combination Therapy in Colon Cancer That Has Come Back or Has Spread
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of Nivolumab Alone or Nivolumab Combination Therapy in Colon Cancer That Has Come Back or Has Spread
Official Title: A Phase 2 Clinical Trial of Nivolumab, or Nivolumab Combinations in Recurrent and Metastatic Microsatellite Instability High (MSI-H) and Non-MSI-H Colon Cancer
Study ID: NCT02060188
Study Description
Brief Summary: The purpose of this study is to examine if Nivolumab by itself, or Nivolumab in combination with other anti-cancer drugs, will result in meaningful tumor size reduction, in participants with colon cancer that has come back or has spread, and who have a specific biomarker in their tumors.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Local Institution - 0028, Gilbert, Arizona, United States
Local Institution - 0004, Los Angeles, California, United States
Local Institution - 0001, San Francisco, California, United States
Local Institution - 0008, Atlanta, Georgia, United States
Local Institution - 0002, Boston, Massachusetts, United States
Local Institution - 0036, Boston, Massachusetts, United States
Allina Health System dba Virginia PIper Cancer Institute, Minneapolis, Minnesota, United States
Local Institution - 0034, Minneapolis, Minnesota, United States
Local Institution - 0024, Durham, North Carolina, United States
Local Institution - 0029, Winston-Salem, North Carolina, United States
Local Institution - 0005, Portland, Oregon, United States
Local Institution - 0041, Allentown, Pennsylvania, United States
Local Institution - 0013, Pittsburgh, Pennsylvania, United States
Local Institution - 0006, Nashville, Tennessee, United States
Local Institution - 0003, Houston, Texas, United States
Local Institution - 0040, Westmead, New South Wales, Australia
Local Institution - 0039, Southport, Queensland, Australia
Local Institution - 0037, Melbourne, Victoria, Australia
Local Institution - 0019, Brussels, , Belgium
Local Institution - 0018, Brussels, , Belgium
Local Institution - 0020, Leuven, , Belgium
Local Institution - 0027, Edmonton, Alberta, Canada
Local Institution - 0016, Toronto, Ontario, Canada
Local Institution - 0025, Paris, , France
Local Institution - 0022, Dublin 4, , Ireland
Local Institution - 0023, Dublin 9, , Ireland
Local Institution - 0033, Galway, , Ireland
Local Institution - 0030, Candiolo, Torino, , Italy
Local Institution - 0035, Modena, , Italy
Local Institution - 0032, Padova, , Italy
Local Institution - 0012, Madrid, , Spain
Local Institution - 0010, Madrid, , Spain
Local Institution - 0011, Sevilla, , Spain
Contact Details
Name: Bristol-Myers Squibb
Affiliation: Bristol-Myers Squibb
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
